Detection of Cauda Equine Syndrome with 18F-FDG PET/CT and Leptomeningeal Metastasis by 68Ga-DOTATATE in the Same Patient with Large Cell Neuroendocrine Carcinoma of Lung


ARSLAN E., Erol Ö., BEYHAN E., Sahin R., Çermik T. F.

Clinical Nuclear Medicine, cilt.46, sa.6, ss.488-490, 2021 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 46 Sayı: 6
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1097/rlu.0000000000003575
  • Dergi Adı: Clinical Nuclear Medicine
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.488-490
  • Anahtar Kelimeler: F-18-FDG PET/CT, Ga-68-DOTATATE PET/CT, cauda equine syndrome (CES), leptomeningeal metastasis, large cell neuroendocrine carcinoma (LCNEC)
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Leptomeningeal metastasis is the metastatic spread of the disease to leptomeninges from solid tumors such as breast, lung cancer, and melanoma. Cauda equine syndrome is a neurological condition caused by compression of the cauda equine. The incidence of large cell neuroendocrine carcinoma in resected lung cancers appears to be 2.1% and 3.5%. The incidence of clinically diagnosed leptomeningeal metastasis in patients with solid tumors is approximately 5%. Here, we present cauda equine syndrome caused by the metastasis of large cell neuroendocrine carcinoma detected by 18F-FDG PET/CT and also 68Ga-DOTATATE PET/CT.